CDT News | Roxom Stocks

1 BTC

=

- USD

Loading market data...

CD

Mkt Cap

$161,082

Volume

11.55M

Next Earnings

November 12th

Chart Bitcoin Treasury Financials Earnings News About Insider Filings

CDT Provides Capital Update and Confirms No Nasdaq DeficienciesCDT Equity Inc. (Nasdaq: CDT) announced 13.7 million shares outstanding as of August 31, 2026, with a market capitalization of approximately $23.0 million. The company confirmed it no longer has outstanding deficiencies with Nasdaq following recent share issuances and corporate actions. CDT, a data-driven biopharmaceutical development company, reported stockholders' equity of approximately $103 million as of June 30, 2026.GlobeNewswire Inc. · Sep 2, 2026

CDT Validates Enhanced Solid-Form Properties Within Its IP PortfolioCDT Equity Inc. announced the development of new solid forms and crystal structures of its existing drug compounds with improved stability, solubility, and manufacturability. The company has filed patents for new therapeutic uses identified through AI-driven analysis, targeting underserved patient populations. CDT plans to advance these findings through laboratory models and pursue licensing partnerships, aiming to create a differentiated, patent-protected portfolio with reduced scientific risk.GlobeNewswire Inc. · Aug 28, 2026

CDT Announces Investment in Pep'd, Expanding into the Fast-Growing US Peptide MarketCDT Equity Inc. (Nasdaq: CDT) announced a SAFE note investment in Pep'd Inc., a US-based peptide telehealth company, to gain exposure to the growing peptide therapeutics market projected to reach $294.6 billion by 2033. The investment leverages AI-enabled approaches for peptide development and combines telehealth with research capabilities. Pep'd is controlled by CDT's CEO Dr. Andrew Regan.GlobeNewswire Inc. · Aug 25, 2026

What's Going On With CDT Equity Shares On Monday?CDT Equity (NASDAQ:CDT) shares rose 14.71% to $4.68 on Monday despite the health care sector declining 2.63% over the past 30 days. The rally comes after the biopharmaceutical company disclosed a widened net loss of $39.1 million for 2025 and filed a non-timely 10K. Technical analysis shows the stock trading 49.1% below its 20-day moving average and 84.6% below its 100-day moving average, with the stock down 99.83% over the past 12 months. The company is set to report earnings on April 24.Benzinga · Apr 13, 2026

CDT Positions for Transformational GrowthCDT Equity Inc. (NASDAQ:CDT) announced multiple strategic initiatives to enhance shareholder value, including its 20% equity stake acquisition in Sarborg AI for $115 million, continued development of its pharmaceutical portfolio with AstraZeneca-licensed assets, and evaluation of capital markets initiatives to strengthen financial flexibility.Benzinga · Mar 4, 2026

Conduit Pharmaceuticals Announces Debt Restructuring and Additional NotesConduit Pharmaceuticals has restructured a $2.65 million loan note with Nirland Limited, removing restrictive clauses and making the note convertible. The company has also secured $1.2 million in new promissory notes, positioning it to access its At-The-Market (ATM) facility to support its note repayment obligations, operations, and clinical objectives.GlobeNewswire Inc. · Nov 1, 2024

Why Bloom Energy Group Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket - BenzingaBloom Energy shares jumped 12.1% after announcing a strategic partnership with CoreWeave to deploy its fuel cells for on-site power generation at a data center. Several other stocks also saw significant pre-market movements, both positive and negative.Benzinga · Jul 17, 2024

What Happened With Conduit Pharmaceuticals (CDT) Stock Today? - BenzingaConduit Pharmaceuticals shares traded higher by over 50% after the company announced it received patent approval for its lead asset targeting autoimmune diseases, which allows it to participate in the Patent Prosecution Highway and enhances the likelihood of approvals in major jurisdictions.Benzinga · Jul 16, 2024

Why Match Group Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - BenzingaMatch Group shares jumped 8% in pre-market trading after Starboard Value took a stake of over 6.5% in the company and is advocating for a potential sale. Several other stocks also saw significant pre-market movement.Benzinga · Jul 16, 2024

Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe’s Leading Life Sciences HubSAN DIEGO and LONDON, March 11, 2024 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) ("Conduit Pharmaceuticals" or "Conduit") today announced the opening of cutting-edge laboratory space in Cambridge, United Kingdom, a global centre for research and development for companies at the forefront of life science innovation. This strategic acquisition marks a pivotal milestone for Conduit, positioning the Company for portfolio expansion, enhanced development capabilities, and growth of a robust intellectual property portfolio.GlobeNewswire Inc. · Mar 11, 2024

CD

CDTCDT Equity Inc. Common Stock

CDT

Pay with—

Available Balance0.00

Your PositionYou don't own any CDT yet.

Related Tickers

Earnings